Trial Profile

Do Endotypes Predict Response and Sequelae in OSA Patients

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 04 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Eszopiclone (Primary) ; Oxygen
Indications Sleep apnoea syndrome
Focus Pharmacodynamics; Therapeutic Use
Acronyms ExPRESSION

Most Recent Events

22 May 2024 Results of preliminary analysis (n=62)presented at the 120th International Conference of the American Thoracic Society
23 Feb 2022 Status changed from not yet recruiting to recruiting.
12 Oct 2021 Planned End Date changed from 1 Jun 2026 to 1 Jan 2027.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com